A pilot phase II trial of celecoxib in patients with grade 2 or 3 endometrioid-type, clear cell, and papillary serous uterine cancers.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2012
At a glance
- Drugs Celecoxib (Primary)
- Indications Uterine cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Apr 2012 Actual end date (1 Mar 2004) added as reported by ClinicalTrials.gov.
- 23 Apr 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.